Optimizing statin therapy in HIV-infected patients: a review of pharmacotherapy considerations
Abstract Background People living with HIV (PLWH) are more vulnerable to cerebrovascular disease, including coronary artery disease. Dyslipidemia is a risk factor for major adverse cardiovascular events in this population as a whole. Dyslipidemia might result from general risk factors, HIV itself, o...
Saved in:
| Main Authors: | Ramin Ansari, Hossein Khalili, Keyhan Mohammadi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-025-04887-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacotherapy with statins in highand very high-risk elderly patients
by: V. V. Simerzin, et al.
Published: (2020-11-01) -
HIV INFECTION AND CARDIOVASCULAR COMPLICATIONS
by: S. S. Yakushin, et al.
Published: (2014-07-01) -
Drug induced liver injury in HIV patients on dolutegravir based antiretroviral therapy regimens in Wolaita Sodo comprehensive specialized hospital
by: Firew Abraham, et al.
Published: (2025-07-01) -
Virological impact of HIV drug-resistance testing in children, adolescents, and adults failing first-line ART in Tanzania
by: Shimba Henerico, et al.
Published: (2024-12-01) -
Strategies for choice of antiretroviral therapy in patients with HIV infection and concomitant cardiovascular disease: A review
by: Vasily I. Shakhgildyan, et al.
Published: (2025-01-01)